Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in mild-to-moderate COPD
NCT02579772Phase 4Completed
- Sponsor
- Queen's University
- Start
- Jul 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, triple-blind trial of acetylcysteine in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Queen's University. Primary endpoints: Plasma Redox Status - Circulating Glutathione at Day 4 and Exercise Capacity - Time to Exhaustion at Day 4. Started Jul 2015; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02579772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579772.